Clarification of pathogenesis and development of therapeutic strategy for small-for size syndrome after major hepatectomy in biliary tract cancer

胆道癌肝大部切除术后小体积综合征发病机制的阐明及治疗策略的制定

基本信息

  • 批准号:
    17390361
  • 负责人:
  • 金额:
    $ 10.11万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

(1)Clinical StudyPostoperative hepatic insufficiency is a critical complication after extended hepatic resection in patients with biliary tract malignancies, the majority of whom suffer from obstructive jaundice. The aim of this study was to assess clinical parameters linked to this type of liver dysfunction.Methods : A total of 111 patients were retrospectively reviewed. Patient background, pre- and intra-operative parameters, and a ratio of remnant liver volume/entire liver volume (RLV/ELV) as a volumetric parameter, were compared between patients with and without postoperative hyperbilirubinemia and subsequent fatal outcome.Results : Logistic regression indicated that only RLV/ELV ratio was an independent factor influencing postoperative hyperbilirubinemia, and RLV/ELV ratio and indocyanine green retention rate at 15 minutes (ICG-R15) were factors affecting survival. Patients with RLV/ELV<40% had 7.6 times the risk of postoperative hyperbilirubinemia, while no patients having RLV/EL … More V>40% and ICG-R15<25% died of liver failure.Conclusions : The RLV/ELV ratio was the factor with the greatest impact on liver dysfunction after extended hepatic resection in patients with biliary tract malignancies. To prevent these morbidities, volumetric analysis should be performed in a prospective fashion, and, when necessary, preoperative portal vein embolization, or, if possible, limited hepatic resection should be applied.(2)Experimental StudyThe effects of obstructive jaundice on liver regeneration after partial hepatectomy are not yet fully understood.Methods : Hepatocyte growth factor (HGF), its receptor, c-Met, vascular endothelial growth factor (VEGF) and transforming growth factor-f31 (TGF-β1) mRNA expression in both liver tissue and isolated liver cells were investigated after biliary obstruction (BO) by quantitative reverse-transcription polymerase chain reaction (RT-PCR) using a LightCycler. Immunohistochemical staining for desmin and α-smooth muscle actin (α-SMA) was also studied. Regenerating liver weight and proliferating cell nuclear antigen (PCNA) labeling index, and growth factor expression were then evaluated after 70% hepatectomy with concomitant internal biliary drainage in BO rats or sham-operated rats.Results : Hepatic TGF-β1 mRNA levels increased significantly 14 days after BO, and further increased with length of cholestasis. Meanwhile, HGF and VEGF tended to increase, but was not significant. In cell isolates, TGF-β1 mRNA was found mainly in the hepatic stellate cell (HSC) fraction. Immunohistochemical studies revealed increased number of HSCs (desmin-positive cells) and activated HSCs (α-SMA-positive cells) in portal areas after BO. In a hepatectomy model, liver regeneration was delayed in BO rats, as compared to sham-operated rats. TGF-β1 mRNA was significantly up-regulated up to 48h after hepatectomy, and the earlier HGF mRNA peak was lost in BO rats.Conclusion : BO induces HSCs proliferation and activation, leading to up-regulation of TGF-β1 mRNA and suppression of HGF mRNA in livers. These altered expression patterns may be strongly involved in delayed liver regeneration after hepatectomy with obstructive jaundice. Less
(1)临床研究肝功能不全是胆道恶性肿瘤扩大肝切除术后的严重并发症,其中绝大多数伴有梗阻性黄疸。本研究的目的是评估与这种类型的肝功能dysfunction.Methods:共111例患者进行了回顾性分析的临床参数。患者背景,术前和术中参数,以及残肝体积/整个肝脏体积(RLV/ELV)的比值作为体积参数,在有和没有术后高胆红素血症和随后的致命结局的患者之间进行比较。Logistic回归分析显示,仅RLV/ELV比值是影响术后高胆红素血症的独立因素,RLV/ELV比值和吲哚菁绿色留存率(ICG-R15)是影响存活的因素。RLV/ELV<40%的患者术后发生高胆红素血症的风险是正常人的7.6倍,而无RLV/EL的患者术后发生高胆红素血症的风险是正常人的7.6倍。 ...更多信息 结论:RLV/ELV比值是影响胆道恶性肿瘤扩大肝切除术后肝功能损害的最重要因素。为了预防这些疾病,应前瞻性地进行体积分析,必要时,术前门静脉栓塞,或如果可能的话,应进行有限的肝切除术。(2)实验研究梗阻性黄疸对肝部分切除术后肝再生的影响尚不完全清楚。肝细胞生长因子(HGF),其受体,c-Met,采用定量逆转录-聚合酶链反应(RT-PCR)技术检测胆道梗阻(BO)后肝组织和肝细胞中血管内皮生长因子(VEGF)和转化生长因子-f31(TGF-β1)mRNA的表达。使用LightCycler进行转录聚合酶链反应(RT-PCR)。免疫组织化学染色结蛋白和α-平滑肌肌动蛋白(α-SMA)。结果:BO后14 d,肝组织TGF-β1 mRNA表达明显增加,并随胆汁淤积时间延长而增加。HGF、VEGF有升高趋势,但无统计学意义。在细胞分离物中,TGF-β1 mRNA主要在肝星状细胞(HSC)组分中发现。免疫组织化学研究显示BO后汇管区HSC(结蛋白阳性细胞)和活化的HSC(α-SMA阳性细胞)数量增加。在肝切除模型中,与假手术大鼠相比,BO大鼠的肝再生延迟。结论:BO可诱导肝星状细胞增殖和活化,导致肝组织TGF-β 1 mRNA表达上调,HGF mRNA表达下调。这些改变的表达模式可能与梗阻性黄疸肝切除术后延迟的肝再生密切相关。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Should the inferior vena cava be reconstructed after resection for malignant tumors?
  • DOI:
    10.1016/j.amjsurg.2005.01.010
  • 发表时间:
    2005-04-01
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Yoshidome, H;Takeuchi, D;Miyazaki, M
  • 通讯作者:
    Miyazaki, M
Decreased cell-mediated Immune status in colorectal cancer patients with hepatic metastasis
结直肠癌肝转移患者细胞介导的免疫状态下降
胆嚢癌手術における拡大肝切除とその適応
扩大肝切除及其在胆囊癌手术中的适应证
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    宮崎 勝;他
  • 通讯作者:
胆嚢癌における血管合併切除の問題点とその意義
胆囊癌联合血管切除术的问题及意义
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    宮崎 勝;他
  • 通讯作者:
Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy
  • DOI:
    10.3748/wjg.v12.i13.2053
  • 发表时间:
    2006-04-07
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    Makino, Hironobu;Shimizu, Hiroaki;Miyazaki, Masaru
  • 通讯作者:
    Miyazaki, Masaru
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIYAZAKI Masaru其他文献

MIYAZAKI Masaru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIYAZAKI Masaru', 18)}}的其他基金

Molecular mechanisms of tumorigenesis of enteric and pancreatic neuroendocrine tumor and development of new molecular targeting therapy.
肠胰神经内分泌肿瘤发生的分子机制及新型分子靶向治疗的发展。
  • 批准号:
    23659638
  • 财政年份:
    2011
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Increased circulating cell signaling phosphoproteins in sera are useful for early detection and the tailor-made therapy for pancreatic and biliary duct cancer patients.
血清中循环细胞信号磷蛋白的增加有助于胰腺癌和胆管癌患者的早期检测和定制治疗。
  • 批准号:
    21390372
  • 财政年份:
    2009
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanism of Liver Organogenesis and Its Application to Liver
肝脏器官发生机制及其在肝脏中的应用
  • 批准号:
    14370376
  • 财政年份:
    2002
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Expression of Somatostatin-Receptor and Inhibitory Effect of Somatostatin on Cell Proliferation in Hepatobiliary Malignancies
生长抑素受体在肝胆肿瘤中的表达及其对细胞增殖的抑制作用
  • 批准号:
    10671156
  • 财政年份:
    1998
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisns of Post-operatire Hepatic Failure after Extended Hepatectomy
扩大肝切除术后肝衰竭的机制
  • 批准号:
    07671363
  • 财政年份:
    1995
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 10.11万
  • 项目类别:
Molecular Determinants of liver sinusoidal endothelial cells for hepatic regeneration
肝窦内皮细胞肝再生的分子决定因素
  • 批准号:
    10682071
  • 财政年份:
    2023
  • 资助金额:
    $ 10.11万
  • 项目类别:
Predicting Future Liver Remnant Function and Growth Trajectory Using Novel MR Imaging Biomarkers
使用新型 MR 成像生物标志物预测未来的肝脏残余功能和生长轨迹
  • 批准号:
    10749468
  • 财政年份:
    2023
  • 资助金额:
    $ 10.11万
  • 项目类别:
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
  • 批准号:
    10633557
  • 财政年份:
    2023
  • 资助金额:
    $ 10.11万
  • 项目类别:
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
  • 批准号:
    10607301
  • 财政年份:
    2023
  • 资助金额:
    $ 10.11万
  • 项目类别:
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease
威尔逊病中核受体功能障碍重新编程代谢和细胞增殖
  • 批准号:
    10516671
  • 财政年份:
    2022
  • 资助金额:
    $ 10.11万
  • 项目类别:
Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH
肝心磷脂水平的恢复和保存促进 AH 中的肝再生
  • 批准号:
    10708057
  • 财政年份:
    2022
  • 资助金额:
    $ 10.11万
  • 项目类别:
Nuclear Receptor Dysfunction Reprograms Metabolism and Cellular Proliferation in Wilson's Disease
威尔逊病中核受体功能障碍重新编程代谢和细胞增殖
  • 批准号:
    10667593
  • 财政年份:
    2022
  • 资助金额:
    $ 10.11万
  • 项目类别:
Alcohol-associated liver disease facilitates lobule scale metabolic reprogramming to modulate regeneration
酒精相关的肝病促进小叶尺度代谢重编程以调节再生
  • 批准号:
    10765601
  • 财政年份:
    2022
  • 资助金额:
    $ 10.11万
  • 项目类别:
Development of a new immunotherapy after hepatectomy using anti-inflammatory cytokines
使用抗炎细胞因子开发肝切除术后新的免疫疗法
  • 批准号:
    22K16535
  • 财政年份:
    2022
  • 资助金额:
    $ 10.11万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了